-
Mashup Score: 2Ibrutinib/Venetoclax Prompts Superior uMRD Data in Elderly or Unfit Patients With CLL - 1 year(s) ago
In an interview with Targeted Oncology, Carolyn Owen, MD, discussed findings from the GLOW study of elderly/unfit patients with chronic lymphocytic leukemia that were presented at SOHO 2022.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Fadi Haddad, MD, discusses the key points from the presentation he gave during the Tenth Annual Meeting of the Society of Hematologic Oncology.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Fadi Haddad, MD, discusses the key points from the presentation he gave during the Tenth Annual Meeting of the Society of Hematologic Oncology. #SOHO22 #ALL #leusm | @MDAndersonNews https://t.co/3c4B3qQW6z
-
-
Mashup Score: 1
In an interview with Targeted Oncology, Kjeld Schmiegelow, MD provided a deep dive into his SOHO 2022 presentation as well as the other acute lymphoblastic leukemia discussions presented during the session.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“I think that we will continue to improve outcomes for children and for adults as we have over the last 1-2 decades. We’re still constantly getting better and better,” said Kjeld Schmiegelow, MD. | #SOHO22 #ALL #leusm https://t.co/HvGscFZQ79
-
-
Mashup Score: 0LP-284 Exhibits Preclinical Efficacy in DDR-Deficient MCL - 1 year(s) ago
LP-284 showed superior antitumor activity compared with LP-184 independent of PTGR1 expression levels in DNA damage repair–deficient mantle cell lymphoma cell lines.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
LP-284 Exhibits Preclinical Efficacy in DDR-Deficient MCL @SocietyofHemOnc #SOHO22 #SOHO2022 #lymsm https://t.co/mAe7ARJkH9
-
-
Mashup Score: 1Educational theme | Disease management of elderly patients with aggressive B-cell lymphoma in the modern era - 1 year(s) ago
Lymphoma Hub recently shared a brief insight on how to improve care for the elderly population. In this review, we will further discuss the strategies for disease management in elderly patients with aggressive B-cell lymphomas, presented by Thieblemont at the Society of Hematologic Oncology (SOHO) 2022 Annual Meeting.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What are the current and future strategies in the disease management of elderly patients with aggressive B-cell #lymphoma, presented at #SOHO22. Read more here 👉 https://t.co/S5hebt8t65. #lymsm https://t.co/gfYgbPSSyO
-
-
Mashup Score: 1Methods of optimizing transplantation in MDS - 1 year(s) ago
Ryotaro Nakamura, MD, City of Hope, Duarte, CA, discusses various methods that may be used to optimize transplantation in myelodysplastic…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Methods of optimizing stem cell transplantation in MDS🩸 Find out more in our exclusive interview with Ryotaro Nakamura of @cityofhope: 🎥: https://t.co/HfjCgL37IF #BMTsm #HemOnc #SOHO22 #MDSsm
-
-
Mashup Score: 1Insights into the Phase II TIDAL study - 1 year(s) ago
Tycel Phillips, MD, City of Hope, Duarte, CA, shares some insights into the Phase II TIDAL study (NCT03768505), which is…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tycel Phillips (@LymphClinician) of @cityofhope shares some insights into the Phase II TIDAL study.💊 Watch here: 👉https://t.co/S0isjl6qxc👈 @SocietyofHemOnc #SOHO22 #HemOnc #LymSM #Lymphoma
-
-
Mashup Score: 1
In an interview with Targeted Oncology, Kjeld Schmiegelow, MD provided a deep dive into his SOHO 2022 presentation as well as the other acute lymphoblastic leukemia discussions presented during the session.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“I think that we will continue to improve outcomes for children and for adults as we have over the last 1-2 decades. We’re still constantly getting better and better,” said Kjeld Schmiegelow, MD. | #SOHO22 #ALL #leusm https://t.co/HvGscFZQ79
-
-
Mashup Score: 1The potential role of cellular therapies and vaccines in the future treatment of MPNs - 1 year(s) ago
Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, briefly discusses the excitement around the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Srdan Verstovsek of @MDAndersonNews briefly discusses the potential role of cellular therapies and vaccines in the future treatment of MPNs: 👉https://t.co/3gr5FvUO9W👈 #MPNsm #SOHO22 #HemOnc #ImmunoOnc @SocietyofHemOnc
-
-
Mashup Score: 1Novel therapeutic regimens being explored in PTCL - 1 year(s) ago
Neha Mehta-Shah, MD, Washington University in St Louis, St Louis, MO, highlights the importance of exploring novel therapeutic combinations in…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find out more about novel treatment regimens being explored in PTCL in our interview with @NehaMehtaShahMD: 👉https://t.co/aCVpVELolB👈 #SOHO22 #Hemonc #LymSM
-
In an interview with Targeted Oncology, Carolyn Owen, MD, discussed findings from the GLOW study of elderly/unfit patients with chronic lymphocytic #leukemia that were presented at #SOHO22. #leusm #CLL https://t.co/PpaazLbUtv